(Q36644465)

English

Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines.

scientific article published on May 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Vladimir Moiseyenko

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Tadeusz Pieńkowski

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

D C Talbot

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

S Van Belle

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

S M O'Reilly

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

S Ackland

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

P Eisenberg

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

D Melnychuk

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

H-U Burger

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

S Laws

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

B Osterwalder

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

British Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

86

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1367-1372

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600261

0 references

Optimizing chemotherapy for patients with advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375384

30 September 2017

Xeloda in the treatment of metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375384

30 September 2017

Phase I-II studies of docetaxel as a single agent in the treatment of metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375384

30 September 2017

Cancer statistics, 1999.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375384

30 September 2017

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375384

30 September 2017

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375384

30 September 2017

Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375384

30 September 2017

Patient preferences for oral versus intravenous palliative chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375384

30 September 2017

Vinorelbine (navelbine) as a salvage treatment for advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375384

30 September 2017

Vinorelbine-induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel--a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375384

28 June 2018

Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375384

20 September 2018

Paclitaxel in Breast Cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375384

20 September 2018

Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11986765

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/11986765

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11986765

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The taxoids: paclitaxel and docetaxel

1 reference

https://pubmed.ncbi.nlm.nih.gov/11986765

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11986765

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11986765

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6600261

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

release_mi37v4xz5fc35o6eqm6vhbnm2i

1 reference

https://api.fatcat.wiki/v0/release/mi37v4xz5fc35o6eqm6vhbnm2i

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11986765%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36644465&oldid=2087161662"